The Impact of Shifting Site of Care on Clinical Research: A Vascular Office-Based Laboratory Approach May 14, 2024
Comprehensive Guidance On Reusable Medical Device Processing Requirements: Cleaning, Disinfection and Sterilization Validations January 25, 2024
Ex Vivo and In Vitro Tissue Models: Applications Supporting an Early Indication of Therapeutic Outcome September 29, 2023
Infectious Disease Diagnostic Devices: The Move to at Home Testing and Treatment (Panel Discussion) August 24, 2023
When Innovation Outpaces Standardization – Solutions to Support Novel Wound Care Product Development July 31, 2023
MedTech Chats: MEGA BIOPHARMA Partners with NAMSA to De-Risk Disruptive Dental Technology February 9, 2023
Exhaustive Extractions in E&L Studies – Endpoint Determination Challenges, Expectations and Reality January 11, 2023
Chemical Characterization Best Practices: Assumptions of TTC and Exhaustive Extraction August 24, 2022
FDA and NAMSA Present: Reducing Regulatory Burden and Streamlining FDA Review through ASCA Pilot Program Utilization July 20, 2022
Virtual Vascular Company Partners with NAMSA to Accelerate 510(k) Clearance by 30 Percent December 18, 2019
Particulates in Preclinical Testing: Understanding the Impact on Overall Device Biological Safety February 15, 2019
Medical Device Reimbursement Strategy: How to Plan for Successful Market Commercialization January 28, 2019
NAMSA APEX Program™ Expedites 510(k) Clearance for Solvay Dental 360™, Delivers 12 Months & $7.5M in Development Savings March 18, 2018
